CREDIT SUISSE AG/ - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 162 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$1,145,994
-35.1%
44,853
-27.1%
0.00%
-50.0%
Q2 2023$1,765,140
+71.4%
61,546
+43.2%
0.00%
+100.0%
Q1 2023$1,030,111
+61.9%
42,975
+14.5%
0.00%0.0%
Q4 2022$636,407
+29.9%
37,524
+13.4%
0.00%0.0%
Q3 2022$490,000
+25.6%
33,087
+33.5%
0.00%
Q2 2022$390,000
-43.6%
24,778
-3.4%
0.00%
-100.0%
Q1 2022$692,000
-28.1%
25,641
-1.4%
0.00%0.0%
Q4 2021$963,000
-18.0%
26,004
+5.8%
0.00%0.0%
Q3 2021$1,174,000
+195.0%
24,571
+108.5%
0.00%
Q2 2021$398,000
-34.4%
11,783
-19.9%
0.00%
Q1 2021$607,000
-71.7%
14,702
-70.3%
0.00%
-100.0%
Q4 2020$2,148,000
-33.7%
49,531
-34.4%
0.00%
-50.0%
Q3 2020$3,240,000
+328.0%
75,561
+366.0%
0.00%
+100.0%
Q2 2020$757,000
+187.8%
16,215
-16.2%
0.00%
Q1 2020$263,000
-59.0%
19,359
-67.2%
0.00%
Q4 2019$641,00059,0030.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2021
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 183,803$9,359,0005.00%
DAFNA Capital Management LLC 229,652$9,852,0003.20%
HealthCor Management, L.P. 1,594,452$68,402,0002.74%
Capital Impact Advisors, LLC 110,000$4,719,0001.40%
Cormorant Asset Management, LP 700,000$30,030,0001.16%
ARK Investment Management 2,495,842$107,072,0000.64%
Millrace Asset Group, Inc. 18,087$776,0000.63%
COOPER CREEK PARTNERS MANAGEMENT LLC 50,532$2,168,0000.54%
Endurant Capital Management LP 34,485$1,479,0000.44%
HealthCor Management, L.P. 200,000$8,580,0000.34%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders